SCHEMBL7975201

SCHEMBL7975201

CC(=O)N1CCN(NC(=O)c2ccc(Oc3ccccc3)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
MAPK1 P28482 1/20 0.51
HTT P42858 2/20 0.50
MMP2 P08253 2/20 0.49
MMP9 P14780 2/20 0.49
GAA P10253 1/20 0.48
KDM4E B2RXH2 2/20 0.47
MAPT P10636 2/20 0.47
NPC1 O15118 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
GALR3 O60755 1/20 0.46
NR2F2 P24468 1/20 0.46
RAB9A P51151 1/20 0.46
CYP2D6 P10635 1/20 0.46
PGR P06401 1/20 0.46
KMT2A Q03164 2/20 0.45
SLC6A7 Q99884 1/20 0.45
EZH2 Q15910 1/20 0.44
MEN1 O00255 1/20 0.44
MAPK14 Q16539 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14590778 0.87 HTT (0.65) HTTGAAMAPTNPC1SMN1; SMN2
SCHEMBL7975184 0.85 HTT (0.54) ALDH1A1MAPK1HTTMAPTNPC1
SCHEMBL7972315 0.85 ALDH1A1 (0.52) ALDH1A1HTTGAAKDM4EMAPT
SCHEMBL8018069 0.83 CYP2D6 (0.53) ALDH1A1MAPK1HTTGAAMAPT
SCHEMBL7958924 0.82 S1PR2 (0.55) ALDH1A1HTTKDM4ENPC1CYP2D6
SCHEMBL7968909 0.80 CYP2D6 (0.50) ALDH1A1HTTGAAMAPTNPC1
SCHEMBL7975166 0.80 EPHX2 (0.51) MMP2MMP9GAACYP2D6
SCHEMBL7972839 0.80 CYP2D6 (0.53) ALDH1A1MAPK1HTTGAAMAPT
SCHEMBL194951 0.79 CYP2D6 (0.72) ALDH1A1HTTGAAKDM4EMAPT
SCHEMBL6581249 0.77 S1PR2 (0.56) ALDH1A1HTTGAAKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291464-B1 POTENTIATION OF THE CHOLINERGIC ACTIVITY; THERAPEUTIC TREATMENT OF AMNESIA, DEMENTIA OR SENILE DEMENTIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-09-18 US disclosed
EP-0968201-A2 NEW AMINOPIPERAZINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-01-05 EP disclosed
WO-1998035951-A2 NEW AMINOPIPERAZINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-08-20 WO disclosed